We are live on ! Find out more
PAHC icon

Phibro Animal Health

154 hedge funds and large institutions have $491M invested in Phibro Animal Health in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 59 increasing their positions, 52 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 52

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

1% less funds holding

Funds holding: 155154 (-1)

5% less capital invested

Capital invested by funds: $516M → $491M (-$24.9M)

2.07% less ownership

Funds ownership: 102.18%100.11% (-2.1%)

Holders
154
Holders Change
-1
Holders Change %
-0.65%
% of All Funds
3.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
59
Reduced
52
Closed
16
Calls
Puts
Net Calls
Net Calls Change

PAHC Hedge Fund Activity: Q1 2020 in Review

154 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q1 2020, worth a combined $491M — down 4.8% from $516M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new PAHC positions and 16 closed out — a net gain of 1 holder — while 59 added to existing stakes and 52 trimmed.

The largest buyer was Principal Financial Group, adding an estimated $24.9M. The largest seller was Morgan Stanley, cutting an estimated $11.9M.

  • 154 institutional investors held Phibro Animal Health (PAHC) as of Q1 2020, down from 155 in Q4 2019.
  • Funds reported $491M of Phibro Animal Health stock for Q1 2020, down 4.8% quarter-over-quarter.
  • 17 funds opened new Phibro Animal Health positions in Q1 2020 and 16 closed out, a net change of +1 holder.
  • The largest Phibro Animal Health buyer in Q1 2020 was Principal Financial Group, an estimated $24.9M added.
  • The largest Phibro Animal Health seller in Q1 2020 was Morgan Stanley, an estimated $11.9M sold.

Based on aggregated 13F filings for Q1 2020.